Table 1 Patients’ baseline characteristics
From: Tissue expression of retinoic acid receptor alpha and CRABP2 in metastatic nephroblastomas
Variable | Value |
|---|---|
Gender (female:male) | 31:46 |
Age (months), median | 26 |
Metastases, n (%) | |
Yes | 17 (22.4) |
No | 59 (77.6)a |
Histological risk group, n (%) | |
High risk | 9 (11.7) |
Intermediate risk | 68 (88.3) |
Lymph nodes, n (%) | |
Negative | 36 (46.8) |
Positive | 4 (5.2)b |
Local stage, n (%) | |
I | 47 (64.4) |
II | 13 (17.8) |
III | 13 (17.8)c |
Histological classification, n (%) | |
Nephroblastoma - epithelial type | 10 (13.0) |
Nephroblastoma - stromal type | 9 (11.7) |
Nephroblastoma - mixed type | 37 (48.1) |
Nephroblastoma - regressive type | 4 (5.2) |
Nephroblastoma - blastemal type | 12 (15.6) |
Nephroblastoma - diffuse anaplasia type | 5 (6.5) |
Clinical evolution, n (%) | |
Disease-free | 57 (74.0) |
Dead | 11 (14.3)d |